Short answer
Oncology Institute, Inc. (TOI) filed an 8-K current report with the SEC on August 21, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation). Item 2.03 disclosure is incomplete, with no borrowing amount, terms, interest rate, maturity, or purpose provided.
Oncology Institute, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.03 · Creation of a Direct Financial Obligation
- Item 2.03 disclosure is incomplete, with no borrowing amount, terms, interest rate, maturity, or purpose provided
Other items in this filing:
- Item 1.01: Entry into a Material Definitive Agreement
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Oncology Institute, Inc. 8-K filings
Get the next TOI 8-K as it lands
Follow TOI for push alerts, or ask the research agent what this filing means.